Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis

Oral Oncology

Volumn 35, Issue 6, 1999, Pages 548-553

  Chen, Qianming ^a   Samaranayake, L P ^a   Zhen, Xin ^a   Luo, Gang ^a   Nie, Minhai ^a   Li, Bingqi ^a  

^a NONE

Author keywords

Fas; FasL; Oral; Premalignant lesions; Squamous cell carcinoma

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ANTIGENS, CD95; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CHINA; DOWN-REGULATION; FAS LIGAND PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MOUTH NEOPLASMS; UP-REGULATION;

EID: 0032705132     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00029-9     Document Type: Article

References (26)

1. Nagato S. Apoptosis by death factor. Cell. 88:1997;355-365.
2. Nagato S., Golstein P. The Fas death factor. Science. 267:1995;1449-1456.
3. Leithauser F., Dhein J., Mechtersheimer G.et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Laboratory Investigation. 69:1993;415-429.
4. Watanabe-Fukunaga R., Brannan C.I.et al. The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. Journal of Immunology. 148:1992;1274-1279.
5. Frech L.E., Hahne M., Viard I.et al. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. Journal of Cell Biology. 133:1996;335-343.
6. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178.
7. Hahne M., Renno T., Schroeter M.et al. Activated B cells express functional fas ligand. European Journal of Immunology. 26:1996;721-724.
8. Loughran T.P.J. Clonal diseases of large granular lymphocytes. Blood. 82:1993;1-14.
9. Strand S., Hofmann W.J., Hug H.et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells: a mechanism of immune evasion? Nature Medicine. 2:1996;1361-1366.
10. Hahne M., Rimoldi D., Schroter M.et al. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science. 274:1996;1363-1366.
11. Niehans G.A., Brunner T., Frizelle S.P.et al. Human lung carcinomas express Fas ligand. Cancer Research. 57:1997;1007-1012.
12. Saas P., Walker P.R., Hahne M.et al. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? Journal of Clinical Investigation. 99:1997;1173-1178.
13. Gratas C., Tohma Y., Van Meir E.G.et al. Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors. Brain Pathology. 7:1997;863-869.
14. O'Connell J., O'Sullivan G.C., Collins J.K., Shanahan F. The Fas-counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. Journal of Experimental Medicine. 184:1996;1075-1082.
15. Shiraki K., Tsuji N., Shioda T., Isselbacher K.J., Takahashi H. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proceedings of the National Academy of Science, USA. 94:1997;6420-6425.
16. Gratas C., Tohma Y., Barnas C.et al. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Research. 58:1998;2057-2062.
17. Yoshioka C., Muraki Y., Fukuda J., Haneji T., Kobayashi N. Identification of the Fas antigen in human gingiva. Journal of Dental Research. 75:1996;1353-1357.
18. Muraki Y., Yoshioka C., Fukuda J., Haneji T., Kobayashi N. Immunohistochemical detection of Fas antigen in oral epithelia. Journal of Oral Pathology and Medicine. 26:1997;57-62.
19. Dekker N.P., Lozada-Nur F., Lagenaur L.A., MacPhail L.A., Bloom C.Y., Regezi J.A. Apoptosis-associated markers in oral lichen planus. Journal Oral Pathology and Medicine. 26:1997;170-175.
20. Chrysomali E., Dekker N.P., Regezi J. Apoptosis in oral erythema multiforme. Oral Surgery Oral Medine Oral Pathology Oral Radiology Endodontics. 83:1997;272-280.
21. Sundelin K., Jadner M., Norberg-Spaak L., Davidsson A., Hellquist H.B. Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue. European Journal of Cancer. 33:1997;1860-1864.
22. Lora L.L., Vintermyr O.K, Johannessen A.C., Liavaag P.G., Jonsson R. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 28:1999;82-87.
23. Chen Q, Luo G, Li B, Samaranayake LP. Expression of p16 and cdk4 in oral premalignant lesions and oral squamous cell carcinomas: a semi-quantitative immunohistochemical study. Journal of Oral Pathology and Medicine 1999;28:158-64.
24. Axell T., Pindborg J.J., Smith C.J., Waal Van Der I. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21, 1994. Journal of Oral Pathology and Medicine. 25:1996;49-54.
25. Pindborg JJ, Reichart PA, Smith CJ, Waal van der I. Histological Typing of Cancer and precancer of the Oral Mucosa, 2nd Edition. World Health Organization, Springer, 1997, p. 11-13.
26. Nie M., Chen Q., Li B., Zhen G., Luo G., Zhen X. A quantitatively pathological study on the lymphocytic infiltrate in oral carcinogenesis. Clinical Journal of Stomatology. 13:1997;213-215. (in Chinese).